Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of...
Sunrise Growers Inc. recalls specific frozen fruit products due to possible Listeria contamination.
U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test.
FDA releases draft recommendations to modernize clinical trials, incorporating RWE, technology, and increasing diversity.
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder...
SILVER SPRING, Md. /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot...
Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6...
FDA clears Beta Bionics iLet ACE Pump & iLet Dosing Decision Software for people with type 1 diabetes.
FDA approves first RSV vaccine, Arexvy, for those 60+ reducing risk of severe LRTD by 94.1%.
FDA supports DCTs, increasing accessibility, diversity, and efficiency in medical research.
